Irbesartan and hydrochlorothiazide
Irbesartan and Hydrochlorothiazide is a prescription medication combining an angiotensin II receptor blocker and a thiazide diuretic to treat high blood pressure. Available in tablets: 150mg irbesartan/12.5mg hydrochlorothiazide and 300mg irbesartan/12.5mg hydrochlorothiazide. Manufactured by Hisun Pharmaceuticals USA Inc. under ANDA 207896. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Irbesartan and Hydrochlorothiazide is a prescription medication combining an angiotensin II receptor blocker and a thiazide diuretic to treat high blood pressure. Available in tablets: 150mg irbesartan/12.5mg hydrochlorothiazide and 300mg irbesartan/12.5mg hydrochlorothiazide. Manufactured by Hisun Pharmaceuticals USA Inc. under ANDA 207896. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Irbesartan and hydrochlorothiazide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Irbesartan and hydrochlorothiazide — ANDA 207896 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207896"
}
]
|
| identifier | ANDA207896 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Irbesartan and hydrochlorothiazide |
